Furthermore, as BPCD increased, PSAD increased (Fig. 5), but the increase was higher in upgraded patients who had higher tumor load in the biopsy cores, but significantly lower PSA mean levels (Fig. 6). This evidence concerns the gene KLK3 and neoplasm.